Source: Health Canada shortage reports · Updated Jul 9, 2026
Fludarabine has no current shortage reported in Canada. It has been in shortage before; the history is below.
A chemotherapy medication used to treat certain leukemias and lymphomas.
Products affected
0 / 3
Reports on file
13
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
FLUDARABINE PHOSPHATE INJECTION, USP
25MG · SOLUTION · ACCORD HEALTHCARE INC
DIN 02438577 · ended Nov 17, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
FLUDARABINE PHOSPHATE FOR INJECTION
25MG · SOLUTION · TEVA CANADA LIMITED
DIN 02283859 · ended Oct 22, 2025 · Disruption of the manufacture of the drug.
Resolved
FLUDARA
10MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02246226 · ended Dec 1, 2025
Resolved
FLUDARA
10MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02246226 · ended Dec 1, 2025
Resolved
FLUDARABINE PHOSPHATE FOR INJECTION
25MG · SOLUTION · TEVA CANADA LIMITED
DIN 02283859 · ended Jul 9, 2025 · Disruption of the manufacture of the drug.
Resolved
FLUDARA
10MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02246226 · ended Nov 2, 2022
Resolved
FLUDARA
10MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02246226 · ended Mar 31, 2023 · Allocation has been initiated and may continue through March 2023.
Resolved
FLUDARABINE PHOSPHATE FOR INJECTION
25MG · SOLUTION · TEVA CANADA LIMITED
DIN 02283859 · ended Dec 10, 2021 · Demand increase for the drug.
Resolved
FLUDARABINE PHOSPHATE FOR INJECTION
25MG · SOLUTION · TEVA CANADA LIMITED
DIN 02283859 · ended Jan 8, 2020 · Disruption of the manufacture of the drug.
Resolved
FLUDARABINE PHOSPHATE FOR INJECTION
25MG · SOLUTION · TEVA CANADA LIMITED
DIN 02283859 · ended Nov 18, 2019 · Shortage of an active ingredient.
Resolved
FLUDARABINE PHOSPHATE FOR INJECTION
25MG · SOLUTION · TEVA CANADA LIMITED
DIN 02283859 · ended Aug 6, 2019 · Disruption of the manufacture of the drug.
Resolved
FLUDARABINE PHOSPHATE FOR INJECTION
25MG · SOLUTION · TEVA CANADA LIMITED
DIN 02283859 · ended Feb 28, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 13 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Fludarabine. Health Canada has 13 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Fludarabine is classified under “ANTIMETABOLITES” (ATC L01BB).
Recent changes
No changes recorded yet.
Common questions
What is Fludarabine used for?
A chemotherapy medication used to treat certain leukemias and lymphomas.
When will Fludarabine be back in stock in Canada?
Fludarabine has no active shortage; supply is normal per Health Canada reports.
Why is Fludarabine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.